HG vs REGN · P/E 6.7, rev $2.91B vs P/E 14, rev $4.29B
Hamilton Insurance Group, Ltd. (HG) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Hamilton Insurance Group, Ltd. (HG) is a insurance - reinsurance company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported HG revenue for 2025-12-31 was $2.91B. Net income was $840.0M. Revenue was up 24.7% from 2024-12-31 to 2025-12-31. HG currently screens at market cap $2.07B and trailing P/E 6.7.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
HG currently screens at market cap $2.07B and trailing P/E 6.7. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the HG and REGN stock pages for the full models.
Not investment advice.